New insights into cancer immunoediting and its three component phases — elimination, equilibrium and escape

Por Mittal, Deepak, Gubin, Matthew M, Schreiber, Robert D, Smyth, Mark J
Publicado no Curr Opin Immunol (2014)

Tumor neoantigens: building a framework for personalized cancer immunotherapy

Por Gubin, Matthew M., Artyomov, Maxim N., Mardis, Elaine R., Schreiber, Robert D.
Publicado no J Clin Invest (2015)

Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4(+) T Cells

Por Techasintana, Patsharaporn, Davis, J. Wade, Gubin, Matthew M., Magee, Joseph D., Atasoy, Ulus
Publicado no PLoS One (2015)

Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip

Por Dahm, Garrett M., Gubin, Matthew M., Magee, Joseph D., Techasintana, Patsharaporn, Calaluce, Robert, Atasoy, Ulus
Publicado em 2012

The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer

Por Calaluce, Robert, Gubin, Matthew M, Davis, J Wade, Magee, Joseph D, Chen, Jing, Kuwano, Yuki, Gorospe, Myriam, Atasoy, Ulus
Publicado em 2010

Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis

Por Chen, Jing, Cascio, Jason, Magee, Joseph D., Techasintana, Patsharaporn, Gubin, Matthew M., Dahm, Garrett M., Calaluce, Robert, Yu, Shiguang, Atasoy, Ulus
Publicado em 2013

Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis

Por Gubin, Matthew M, Calaluce, Robert, Davis, J Wade, Magee, Joseph D, Strouse, Connie S, Shaw, Daniel P, Ma, Lixin, Brown, Ashley, Hoffman, Timothy, Rold, Tammy L, Atasoy, Ulus
Publicado em 2010

Temporally-Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape

Por Noguchi, Takuro, Ward, Jeffrey P., Gubin, Matthew M., Arthur, Cora D., Lee, Sang Hun, Hundal, Jasreet, Selby, Mark J., Graziano, Robert F., Mardis, Elaine R., Korman, Alan J., Schreiber, Robert D.
Publicado no Cancer Immunol Res (2017)

Conditional Knockout of the RNA-Binding Protein HuR in CD4(+) T Cells Reveals a Gene Dosage Effect on Cytokine Production

Por Gubin, Matthew M, Techasintana, Patsharaporn, Magee, Joseph D, Dahm, Garrett M, Calaluce, Robert, Martindale, Jennifer L, Whitney, Maryln S, Franklin, Craig L, Besch-Williford, Cindy, Hollingsworth, John W, Abdelmohsen, Kotb, Gorospe, Myriam, Atasoy, Ulus
Publicado em 2014

Metabolic competition in the tumor microenvironment is a driver of cancer progression

Por Chang, Chih-Hao, Qiu, Jing, O’Sullivan, David, Buck, Michael D., Noguchi, Takuro, Curtis, Jonathan D., Chen, Qiongyu, Gindin, Mariel, Gubin, Matthew M., van der Windt, Gerritje J.W., Tonc, Elena, Schreiber, Robert D., Pearce, Edward J., Pearce, Erika L.
Publicado no Cell (2015)

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

Por Gubin, Matthew M., Zhang, Xiuli, Schuster, Heiko, Caron, Etienne, Ward, Jeffrey P., Noguchi, Takuro, Ivanova, Yulia, Hundal, Jasreet, Arthur, Cora D., Krebber, Willem-Jan, Mulder, Gwenn E., Toebes, Mireille, Vesely, Matthew D., Lam, Samuel S.K., Korman, Alan J., Allison, James P., Freeman, Gordon J., Sharpe, Arlene H., Pearce, Erika L., Schumacher, Ton N., Aebersold, Ruedi, Rammensee, Hans-Georg, Melief, Cornelis J. M., Mardis, Elaine R., Gillanders, William E., Artyomov, Maxim N., Schreiber, Robert D.
Publicado no Nature (2014)